- Previous Close
319.80 - Open
319.80 - Bid 306.00 x --
- Ask 307.50 x --
- Day's Range
306.00 - 315.00 - 52 Week Range
190.00 - 355.00 - Volume
11,170 - Avg. Volume
13,848 - Market Cap (intraday)
42.112M - Beta (5Y Monthly) -0.28
- PE Ratio (TTM)
-- - EPS (TTM)
-0.48 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, RF micro needling, and fractional skin resurfacing. The company was incorporated in 2004 and is based in Freehold, New Jersey.
www.endymed.comRecent News: ENDY.TA
View MorePerformance Overview: ENDY.TA
Trailing total returns as of 1/2/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ENDY.TA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ENDY.TA
View MoreValuation Measures
Market Cap
44.01M
Enterprise Value
22.71M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.63
Price/Book (mrq)
0.91
Enterprise Value/Revenue
0.33
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.26%
Return on Assets (ttm)
-3.28%
Return on Equity (ttm)
-5.53%
Revenue (ttm)
19.6M
Net Income Avi to Common (ttm)
-835k
Diluted EPS (ttm)
-0.48
Balance Sheet and Cash Flow
Total Cash (mrq)
7.36M
Total Debt/Equity (mrq)
7.80%
Levered Free Cash Flow (ttm)
-3.03M